Health & Wellbeing

Symptoms, Diagnosis & Treatment Guide

Learn the key signs of Cushing's disease in dogs, from early symptoms to diagnosis, treatment costs, prognosis, and home care strategies for affected dogs.

By Aaron Whyte · Published 11 September 2026 · Updated 18 October 2026
Symptoms, Diagnosis & Treatment Guide

What Is Cushing's Disease in Dogs?

Cushing's disease, medically known as hyperadrenocorticism (HAC), is an endocrine disorder caused by prolonged overproduction of cortisol — the body's primary stress hormone. In healthy dogs, cortisol is tightly regulated by the pituitary-adrenal axis. When this system breaks down, excess cortisol floods the body, triggering a cascade of metabolic, immune, and dermatological changes that can significantly impact quality of life.

There are three recognized forms of Cushing's disease:

  • Pituitary-dependent hyperadrenocorticism (PDH): Accounts for approximately 80–85% of cases. A benign tumor (adenoma) on the pituitary gland overproduces ACTH, which stimulates the adrenal glands to release excess cortisol.
  • Adrenal-dependent hyperadrenocorticism (ADH): Represents roughly 15–20% of cases. A tumor on one of the adrenal glands directly secretes cortisol independent of pituitary signaling. About 50% of adrenal tumors are malignant (adenocarcinomas).
  • Iatrogenic Cushing's syndrome: Caused by prolonged administration of corticosteroid medications (prednisone, dexamethasone, methylprednisolone) used to treat allergies, autoimmune conditions, or inflammation.

According to the Merck Veterinary Manual, Cushing's disease is one of the most commonly diagnosed endocrine disorders in dogs, affecting an estimated 1 to 2 out of every 1,000 dogs annually. It predominantly strikes middle-aged to older dogs, typically between 7 and 12 years of age.

Key Risk Factors for Cushing's Disease

  • Age: Most commonly diagnosed in dogs 7–12 years old; rare in dogs under 6
  • Breed predisposition: Poodles (especially Miniature and Toy), Dachshunds, Terriers (Yorkshire, Boston, Staffordshire), Beagles, German Shepherds, and Cocker Spaniels are overrepresented
  • Sex: Female dogs are slightly more predisposed, particularly for adrenal tumors
  • Weight: Obesity is not a direct cause but can mask or compound symptoms
  • Medication history: Long-term corticosteroid use (oral, injectable, or topical) significantly increases iatrogenic risk
  • Size: PDH is more common in small-breed dogs; ADH is relatively more frequent in large-breed dogs

Recognizing the Signs of Cushing's Disease in Dogs

One of the most challenging aspects of Cushing's disease is its insidious onset. Symptoms develop gradually over months or even years, and many owners dismiss early changes as normal aging. Understanding the progression from subtle early indicators to advanced clinical signs is critical for timely veterinary intervention.

Early Warning Signs (Often Overlooked)

These symptoms typically appear first and may be present for 6–12 months before a diagnosis is made:

Symptom What You'll Notice Why It Happens
Increased thirst (polydipsia) Water bowl empties faster; dog hovers near faucets or toilets; drinking over 100 mL/kg/day (normal is 40–60 mL/kg/day) Cortisol interferes with antidiuretic hormone (ADH), reducing the kidneys' ability to concentrate urine
Increased urination (polyuria) More frequent outdoor trips; accidents in previously house-trained dogs; larger urine volumes Kidneys produce dilute urine to compensate for excess fluid intake
Increased appetite (polyphagia) Begging intensifies; stealing food; eating non-food items; seeming unsatisfied after meals Cortisol stimulates appetite centers and alters glucose metabolism, creating constant hunger signals
Mild panting increase Panting more at rest or in cool environments; not related to exercise or heat Cortisol weakens respiratory muscles and alters fat distribution around the chest cavity

Advanced Clinical Signs

As the disease progresses untreated, more visible and systemic symptoms emerge:

Symptom What You'll Notice Clinical Significance
Pot-bellied appearance Abdomen appears distended and rounded despite no weight gain elsewhere; "barrel-shaped" torso Cortisol causes protein catabolism of abdominal muscles and redistribution of fat to the liver and abdominal cavity (hepatomegaly)
Muscle wasting Thinning of limbs; visible spine and hip bones; weakness climbing stairs or jumping Chronic cortisol excess breaks down skeletal muscle protein for gluconeogenesis
Skin changes (dermatological signs) Hair loss (alopecia) starting on flanks and trunk; thin, fragile skin that bruises easily; dark hyperpigmented patches; recurrent skin infections Cortisol suppresses hair follicle cycling and compromises skin barrier integrity; calcinosis cutis (calcium deposits) may appear as gritty plaques
Recurrent infections Frequent UTIs; skin infections that don't resolve; ear infections Cortisol is immunosuppressive — it reduces white blood cell function and inflammatory response
Lethargy and behavioral changes Reduced interest in walks/play; sleeping more; restlessness at night; sometimes irritability Muscle weakness, metabolic disruption, and possible neurological effects from pituitary macroadenomas (large tumors)
Hypertension Not visible externally; detected on veterinary exam Cortisol increases vascular sensitivity to catecholamines; present in approximately 46–82% of Cushing's dogs per published studies
💡 Clinical Pearl: The classic "3 Ps" triad — polydipsia (excessive thirst), polyuria (excessive urination), and polyphagia (excessive appetite) — is present in approximately 80% of Cushing's cases. If your dog exhibits all three alongside a pot-bellied appearance and hair loss, Cushing's should be high on the differential diagnosis list.

How Is Cushing's Disease Diagnosed in Dogs?

Diagnosing Cushing's disease is among the more complex endocrine workups in veterinary medicine. No single test is 100% definitive, and veterinarians typically use a staged approach combining clinical suspicion with sequential laboratory testing. According to the American College of Veterinary Internal Medicine (ACVIM) consensus statements, diagnosis requires both compatible clinical signs AND confirmatory laboratory results.

Step-by-Step Diagnostic Process

  1. Initial Screening — Complete Blood Count (CBC) and Serum Biochemistry Panel
    Your vet will first run baseline blood work. Findings suggestive of Cushing's include: elevated alkaline phosphatase (ALP) — seen in over 90% of cases, elevated ALT, stress leukogram (elevated neutrophils, low lymphocytes and eosinophils), hypercholesterolemia, and hyperglycemia. Dilute urine (urine specific gravity below 1.020) on urinalysis is also a hallmark. Estimated cost: $150–$300.
  2. Urine Cortisol:Creatinine Ratio (UCCR)
    A first-morning urine sample collected at home (to avoid stress-induced cortisol elevation from the clinic visit). A normal UCCR effectively rules out Cushing's (high sensitivity), but an elevated result is not specific — stress, illness, and other conditions can raise it. This is a screening test, not a confirmatory one. Estimated cost: $50–$100.
  3. Low-Dose Dexamethasone Suppression Test (LDDST)
    Considered the gold-standard screening test for PDH. A small dose of dexamethasone (0.01 mg/kg IV) is administered, and blood cortisol levels are measured at 0, 4, and 8 hours. In healthy dogs, dexamethasone suppresses cortisol production. In Cushing's dogs, suppression fails. The LDDST can also help differentiate PDH from ADH in some cases (if cortisol suppresses at 4 hours but escapes at 8 hours, PDH is likely). Estimated cost: $200–$350.
  4. ACTH Stimulation Test
    Synthetic ACTH (cosyntropin, 5 µg/kg IV or IM) is administered, and cortisol is measured before and 1 hour after injection. This test has high specificity for Cushing's but lower sensitivity (approximately 60–65% for PDH, higher for ADH). It is the preferred test when iatrogenic Cushing's is suspected and is essential before starting treatment with mitotane or trilostane to establish a baseline. Estimated cost: $150–$275 (cosyntropin costs have risen significantly in recent years).
  5. High-Dose Dexamethasone Suppression Test (HDDST)
    Used to differentiate PDH from ADH after a Cushing's diagnosis is confirmed. A higher dexamethasone dose (0.1 mg/kg IV) is given, and cortisol is measured at 0, 4, and 8 hours. PDH tumors may still partially suppress at this dose, while adrenal tumors will not. However, this test has been partially supplanted by endogenous ACTH measurement and imaging. Estimated cost: $200–$350.
  6. Endogenous ACTH (eACTH) Concentration
    A direct blood measurement of ACTH levels. High or normal eACTH indicates PDH (the pituitary is driving the process); low or undetectable eACTH indicates ADH (the adrenal tumor is producing cortisol independently, suppressing pituitary ACTH via negative feedback). Sample handling is critical — blood must be collected in a chilled EDTA tube, processed immediately, and frozen for shipping. Estimated cost: $100–$200.
  7. Abdominal Ultrasound
    Directly visualizes the adrenal glands. In PDH, both adrenals are typically normal to mildly enlarged. In ADH, one adrenal gland is enlarged (often with a mass) while the contralateral gland is atrophied (shrunken due to ACTH suppression). Ultrasound also screens for liver enlargement, urinary calculi, and possible metastatic disease. Estimated cost: $300–$600 depending on region and specialist involvement.
  8. Advanced Imaging (CT or MRI)
    Recommended when a pituitary macroadenoma (tumor >10 mm) is suspected based on neurological signs (head pressing, disorientation, visual deficits, seizures) or when surgical planning for adrenalectomy is needed. CT of the abdomen provides detailed adrenal and vascular anatomy; MRI of the brain evaluates pituitary tumor size. Estimated cost: $800–$2,000+ per scan.

Total Diagnostic Cost Range

Basic workup (screening to confirmation): $500–$1,200

Full workup with differentiation and imaging: $1,500–$3,500

Comprehensive workup with advanced imaging: $2,500–$5,000+

Costs vary significantly by geographic region, whether testing is performed at a general practice vs. specialty center, and current reagent availability. Cosyntropin supply disruptions have caused notable price fluctuations in recent years.

Treatment Options for Cushing's Disease in Dogs

Treatment depends on the type of Cushing's (PDH vs. ADH vs. iatrogenic), the dog's overall health, tumor characteristics, and owner budget. The goal is not to "cure" the disease in most cases but to achieve controlled cortisol levels that restore quality of life and prevent complications.

Treatment Type Used For Mechanism Efficacy Ongoing Cost
Trilostane (Vetoryl®) PDH and ADH (first-line medical therapy) Inhibits 3β-hydroxysteroid dehydrogenase, blocking cortisol synthesis in adrenal glands Clinical improvement in 70–85% of dogs within 2–4 weeks; requires lifelong daily dosing (typically twice daily) $50–$150/month depending on dose and dog size
Mitotane (Lysodren®) PDH (alternative; historically first-line) Selectively destroys the zona fasciculata and zona reticularis of the adrenal cortex (controlled adrenal necrosis) Effective in 70–80% of cases; requires careful induction phase with risk of Addisonian crisis (over-treatment) $30–$80/month (drug is less expensive but monitoring is intensive)
Bilateral Adrenalectomy Rarely performed; severe bilateral adrenal disease Surgical removal of both adrenal glands; requires lifelong glucocorticoid and mineralocorticoid replacement Curative but high perioperative risk; permanent Addison's disease results $3,000–$6,000+ surgery plus lifelong hormone replacement
Unilateral Adrenalectomy ADH (adrenal tumor, especially if no metastasis) Surgical removal of the affected adrenal gland; contralateral gland recovers function over weeks Curative for benign adenomas; 1-year survival ~84%, 2-year ~72% for adenocarcinomas without metastasis (per peer-reviewed surgical outcome studies) $3,000–$7,000+ depending on tumor complexity and vascular invasion
Radiation Therapy (SRT/SRS) PDH with pituitary macroadenoma causing neurological signs Stereotactic radiation targets and shrinks the pituitary tumor over weeks to months Neurological improvement in 70–80% of cases; does not always normalize cortisol levels — medical therapy may still be needed concurrently $4,000–$8,000+ (single or multi-fraction protocols)
Gradual Steroid Taper Iatrogenic Cushing's only Slowly reducing exogenous corticosteroid dose under veterinary supervision to allow adrenal axis recovery Fully reversible in most cases over weeks to months; rate depends on duration and dose of prior steroid use Minimal — monitoring visits only ($100–$250 per recheck)

Monitoring During Treatment

Regardless of which medication is used, rigorous monitoring is essential to avoid both under-treatment (persistent Cushing's symptoms) and over-treatment (iatrogenic Addison's disease — an acute, potentially life-threatening cortisol deficiency).

Typical monitoring schedule for trilostane or mitotane:

  • ACTH stimulation test at 10–14 days after starting treatment
  • Repeat ACTH stim at 30 days, then at 90 days
  • Once stable: ACTH stim and biochemistry panel every 3–6 months for life
  • Blood pressure monitoring at each visit (hypertension is a common comorbidity)
  • Owner monitoring of water intake, appetite, energy level, and urination frequency daily at home

⚠️ Never adjust your dog's trilostane or mitotane dose without veterinary guidance. Over-treatment can cause acute hypoadrenocorticism (Addisonian crisis), which presents as vomiting, diarrhea, collapse, and shock — a true medical emergency.

Prognosis and Life Expectancy for Dogs with Cushing's Disease

The prognosis for Cushing's disease varies considerably based on the underlying cause, whether treatment is pursued, tumor characteristics, and the presence of complications such as diabetes mellitus, hypertension, or pulmonary thromboembolism.

Scenario Median Survival Time Key Prognostic Factors
PDH — treated medically (trilostane or mitotane) Approximately 2–2.5 years (median); many dogs live 3–5+ years with good control Age at diagnosis, concurrent diseases (diabetes, kidney disease), owner compliance with monitoring, pituitary tumor size
PDH — untreated Variable; some dogs survive 1–2 years but quality of life deteriorates significantly Risk of fatal complications: pulmonary thromboembolism, severe infections, pancreatitis, diabetic ketoacidosis, pituitary tumor expansion
PDH with pituitary macroadenoma (>10 mm) Shorter median survival (~1 year or less without radiation); improved with radiation therapy Neurological signs at presentation, tumor growth rate, response to radiation, development of Nelson's syndrome-like progression
ADH — benign adenoma, surgically removed Excellent; median survival >3 years; potential for complete cure Surgical experience, perioperative complications, tumor size and vascular invasion
ADH — malignant adenocarcinoma Approximately 12–18 months with surgery; shorter if metastasis present at diagnosis Tumor size (>5 cm is poorer prognosis), vascular invasion, metastasis to liver or lungs, surgical margins
Iatrogenic Cushing's Full recovery expected once steroids are tapered; normal life expectancy Duration of prior steroid use, underlying condition requiring steroids, rate of taper

It's important to note that many dogs with well-managed PDH die from unrelated causes (cancer, kidney failure, cardiac disease) rather than from Cushing's itself. The disease is serious but, when caught and managed appropriately, is very compatible with years of good-quality life.

Home Care and Daily Management

Living with a Cushing's dog requires consistent daily routines and vigilant observation. Here's what a typical management plan looks like in practice:

Medication Administration

  • Trilostane should be given with food (improves absorption) — ideally a meal containing some fat. Most dogs require twice-daily dosing for optimal cortisol control, though some protocols start with once daily.
  • Administer doses at consistent 12-hour intervals (e.g., 7 AM and 7 PM) to maintain stable cortisol suppression.
  • Keep a medication log — note any missed doses, GI upset, or behavioral changes.
  • Never double a missed dose. If you miss a dose and the next one is due within 4 hours, skip it.

Monitoring at Home

  • Water intake: Measure daily water consumption. A useful benchmark: normal is approximately 40–60 mL per kg of body weight per day. A 10 kg (22 lb) dog should drink roughly 400–600 mL (about 2–2.5 cups) daily. Consistent intake above 100 mL/kg/day warrants a vet check.
  • Appetite: Note whether ravenous hunger is normalizing with treatment. Persistent excessive appetite may indicate under-dosing.
  • Activity level: Track willingness to walk, climb stairs, and play. Improving energy is a positive treatment indicator.
  • Coat and skin: Hair regrowth is slow — expect 3–6 months before visible improvement. Photograph affected areas monthly to track progress objectively.
  • Urine output: Monitor frequency and volume. Sudden changes may indicate UTI (very common in Cushing's dogs due to immunosuppression and dilute urine).

Diet and Lifestyle Adjustments

  • Feed a high-quality, AAFCO-approved diet appropriate for your dog's life stage. Moderate protein, moderate fat, and controlled sodium are generally recommended — particularly if hypertension or kidney concerns exist.
  • Avoid high-fat treats and table scraps, as Cushing's dogs are predisposed to pancreatitis and hyperlipidemia.
  • Maintain a healthy body condition score (BCS 4–5 on a 9-point scale). Weight management reduces stress on weakened abdominal muscles and joints.
  • Provide easy access to fresh water at all times — never restrict water intake, even if urination is excessive. Restricting water in a polyuric dog can lead to dangerous dehydration.
  • Gentle, regular exercise (short walks, swimming if available) helps maintain muscle tone without overexertion.

Managing Complications

Cushing's dogs are prone to several secondary conditions that require proactive management:

  • Urinary tract infections: Up to 50% of Cushing's dogs develop UTIs, often without obvious symptoms (due to immunosuppression masking inflammation). Urinalysis with culture should be performed every 3–6 months even in asymptomatic dogs.
  • Hypertension: Blood pressure should be checked at every veterinary visit. Anti-hypertensive medication (amlodipine, telmisartan) may be needed.
  • Diabetes mellitus: Approximately 10–15% of Cushing's dogs develop concurrent diabetes. Controlling Cushing's often improves insulin sensitivity, but some dogs require insulin therapy.
  • Pulmonary thromboembolism (PTE): A serious and potentially fatal complication. Cushing's creates a hypercoagulable state. Signs include sudden respiratory distress, rapid breathing, and collapse — this is an emergency.
  • Gallbladder mucocele: More common in Cushing's dogs; detected on ultrasound. May require surgical intervention if causing obstruction or rupture risk.

The Cost of Cushing's Disease Treatment

Cushing's disease is a chronic condition requiring lifelong investment. Understanding the full financial picture helps owners plan realistically and avoid lapses in care.

Cost Breakdown

Expense Category Estimated Cost Range (USD) Frequency
Initial diagnostic workup (blood work, urine tests, LDDST or ACTH stim) $500–$1,500 One-time
Differentiation testing (HDDST, eACTH, ultrasound) $500–$1,500 One-time
Advanced imaging (CT or MRI) if indicated $1,000–$2,500 One-time (or repeated if monitoring tumor)
Trilostane (Vetoryl®) medication $50–$150/month Monthly, lifelong
Mitotane (Lysodren®) medication $30–$80/month Monthly, lifelong (maintenance phase)
Monitoring visits (ACTH stim + biochemistry panel) $200–$450 per visit Every 3–6 months once stable; more frequently in first 3 months
Adrenal surgery (unilateral adrenalectomy) $3,000–$7,000+ One-time (specialist surgery)
Pituitary radiation therapy $4,000–$8,000+ One-time treatment course
Treatment of complications (UTIs, pancreatitis, hypertension medications) $100–$800+ per incident As needed

First-year total cost estimate (medical management of PDH): $2,000–$5,000 depending on diagnostic complexity and geographic location.

Ongoing annual cost (stable, uncomplicated case): $1,200–$3,000 per year for medication and monitoring.

Worst-case scenario (surgery, radiation, or severe complications): $8,000–$15,000+ in the first year.

Pet insurance can be valuable here — if enrolled before diagnosis, many plans cover diagnostic testing, medications, and surgery. However, Cushing's diagnosed before enrollment will be excluded as a pre-existing condition. Review policy terms for endocrine disease coverage and annual/lifetime limits carefully.

When to See the Vet Immediately

🚨 Emergency Red Flags — Seek Veterinary Care Now

Contact your veterinarian or an emergency veterinary hospital immediately if your dog exhibits any of the following:

  • Sudden collapse, extreme weakness, or inability to stand — may indicate Addisonian crisis (over-treatment), pulmonary thromboembolism, or adrenal tumor rupture
  • Severe vomiting and/or diarrhea — especially if persistent, bloody, or accompanied by lethargy (possible Addisonian crisis or pancreatitis)
  • Sudden difficulty breathing or rapid, labored respiration — may indicate pulmonary thromboembolism, a known fatal complication of Cushing's
  • Neurological signs: head pressing, disorientation, circling, seizures, or sudden blindness — may indicate pituitary macroadenoma expansion or stroke
  • Acute abdominal distension with pain — possible gallbladder mucocele rupture or other abdominal emergency
  • Known Cushing's dog on trilostane or mitotane who becomes acutely ill — withhold the next medication dose and contact your vet; this could be iatrogenic hypoadrenocorticism requiring emergency IV fluids and glucocorticoids

ASPCA Animal Poison Control: (888) 426-4435 (24/7, consultation fee applies) — call if your dog accidentally ingests a large quantity of medication or a human corticosteroid.

For non-emergency situations, schedule a veterinary appointment promptly if you notice:

  • Gradual increase in thirst and urination over several weeks
  • New or worsening hair loss, particularly symmetrical on the trunk
  • Progressive abdominal enlargement
  • Recurrent skin or ear infections that don't resolve with standard treatment
  • Changes in appetite or energy level in a middle-aged or senior dog

Important: This guide is intended for educational purposes. Only a licensed veterinarian can diagnose Cushing's disease and prescribe appropriate treatment. Always consult your veterinarian before making any changes to your dog's medication, diet, or care plan.

Frequently Asked Questions

Can Cushing's disease in dogs be cured?

In most cases, Cushing's disease is managed rather than cured. Pituitary-dependent Cushing's (80–85% of cases) requires lifelong medication because the pituitary tumor cannot typically be removed. Adrenal-dependent Cushing's caused by a benign adenoma can be cured through surgical removal of the affected adrenal gland, provided there is no metastasis. Iatrogenic Cushing's is fully reversible once exogenous steroids are tapered under veterinary supervision.

Which dog breeds are most prone to Cushing's disease?

Breeds with documented predisposition include: Poodles (Miniature and Toy varieties especially), Dachshunds, various Terriers (Yorkshire Terrier, Boston Terrier, Staffordshire Bull Terrier), Beagles, German Shepherds, Cocker Spaniels, and Bichon Frises. However, Cushing's can develop in any breed. Small-breed dogs are generally overrepresented for PDH, while larger breeds have a relatively higher proportion of adrenal tumors.

How long can a dog live with untreated Cushing's disease?

Untreated Cushing's disease is not immediately fatal, but it progressively degrades quality of life and increases the risk of life-threatening complications. Without treatment, median survival is estimated at 1–2 years, though some dogs survive longer. The primary risks of untreated disease include pulmonary thromboembolism (blood clots in the lungs), severe infections due to immunosuppression, congestive heart failure, pancreatitis, diabetes mellitus, and neurological deterioration from expanding pituitary tumors.

Is Cushing's disease painful for dogs?

Cushing's disease itself is not typically painful in the way that arthritis or dental disease is. However, it causes significant discomfort through muscle weakness, skin infections, chronic hunger, and restlessness. Complications such as pancreatitis, UTIs, calcinosis cutis (calcium deposits in the skin), and gallbladder mucoceles can be painful. Most owners report a noticeable improvement in their dog's demeanor and comfort within 2–4 weeks of starting effective treatment.

Can diet alone treat Cushing's disease?

No. There is no diet, supplement, or natural remedy that can treat or reverse Cushing's disease. While proper nutrition supports overall health and helps manage secondary issues like hyperlipidemia and obesity, the underlying hormonal imbalance requires medical or surgical intervention. Be cautious of online claims suggesting that herbal supplements, melatonin, or lignans can replace prescribed medication — while some supplements may have mild supportive effects on coat quality, they do not address cortisol overproduction. Always discuss any supplement with your veterinarian before adding it to your dog's regimen.

What happens if I miss giving my dog's trilostane dose?

Missing a single dose is generally not dangerous. Administer the next dose at the regular scheduled time — do not double the dose to "make up" for the missed one. Cortisol levels will temporarily rise, and you may notice a brief increase in thirst or appetite, but this typically resolves with the next dose. If you miss multiple consecutive doses (e.g., over a weekend), contact your veterinarian for guidance on whether a recheck ACTH stimulation test is needed before resuming.

Are there any new treatments for Cushing's disease in dogs?

Research into Cushing's disease management is ongoing. Recent areas of investigation include: osilodrostat (a newer 11β-hydroxylase inhibitor used in human Cushing's, being studied for veterinary use), improved stereotactic radiation protocols for pituitary macroadenomas, and laparoscopic adrenalectomy techniques that reduce surgical morbidity. Consultation with a veterinary internal medicine specialist (DACVIM) is recommended for dogs with complex or refractory cases to access the most current treatment options.

Written by

Aaron Whyte

All our authors care for dogs every day — read more of their work on the authors page.